Skip to main content
. 2020 Feb 21;21(4):1461. doi: 10.3390/ijms21041461
FDA Food and Drug Administration
MMR mismatch repair
IHC immunohistochemistry
MLH1 mutL homologue 1
MSH2 mutS homologue 2
MSH6 mutS homologue 6
PMS2 postmeiotic segregation increased 2
MSI Microsatellite instability
hMMR MMR-heterogeneous
dMMR MMR-deficient
pMMR MMR-proficient
PTEN Phosphatase and tensin homolog
PI3K phosphatidylinositol-3-kinase
Akt protein kinase B
BCIRG Breast Cancer International Research Group
ER estrogen receptor
SCNA somatic copy number alteration
HR hazard ratio
PPV positive predictive value
PR progesterone receptor
LDT locally developed tests
TNBCs triple-negative breast cancers
TMAs tissue microarrays
PD-L1 programmed death-ligand 1
IRB Institutional Review Board
SD standard deviation
WHO World Health Organization
AJCC American Joint Committee on Cancer
FFPE formalin-fixed, paraffin-embedded
CAP College of American Pathologists
OR odds ratio
CI confidence interval